1Hundahl SA, Phillips JL, Menck HR, et al. The National Cancer Data Base Report on poor survival of U. S. gastric carcinoma pa- tients treated with gastrectomy:Fifth Edition American Joint Com- mittee on Cancer Staging. Proximal disease, and the " different disease" hypothesis [J]. Cancer,2000,88(4) :921-932.
2Zhang ZX, Gu XZ, Yin WB, et al. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric eardia ( AGC ) report on 370 pa- tients [ J ]. Int J Radiat Oneol Biol Plays, 1998,42 (5) :929-934.
3Skoropad V, Berdov B,Zagrebin V,et al, Concentrated preoperative radiotherapy for resectable gastric cancer: 20-years follow-up of a randomized trial [ J ]. J Surg Oncol,2002,80 (2) :72-78.
4Fiorica F, Cartel F, Enea M, et al. The impact of radiotherapy on survival in respectable gastric carcinoma:a meta-analysis of litera- ture data[ J]. Cancer Treat Rev,2007,33 ( 8 ) :729-740.
5Buergy D, Lohr F, Baack T,et al. Radiotherapy for tumors of the stomach and gastroesophageal junction a review of its role in muhimodal therapy [ J ]. Radiat Oncol,2012,7 : 192.
6Martin S, Chen JZ, Rashid Dar A, et al. Dosimetric comparison of he'tieal tomotherapy, RapidArc, and a novel IMRT & Arc technique for esophageal carcinoma [ J 1. Radiother Oncol, 2011,101 ( 3 ) : 431-437.
7Fan T,Jiang G, Suo Z, et al. Down-regulation of the apoptosis-indu- cing factor or Bcl-2 inhibitor of transcription by RNA interference can alleviate TAp63gamma-induced apoptosis in esophageal squa- mous carcinoma EC9706 cells [J]. Int J Oncol, 2009,35 ( 2 ) : 359 -367.
8Nicolini G, Ghosh-Laskar S, Shrivastava SK, et al. Volumetric mod- ulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for ad- vanced esophageal cancer: a feasibility study[ J]. Int J Radiat On- col Biol Phys,2012,84(2) :553-560.
9Vivekanandan N, Sriram P, Kumar SA, et al. Volumetric modula- ted arc radiotherapy for esophageal cancer [ J ]. Med Dosim,2012, 37(1) :108-113.
10Van Benthuysen L, Hales L, Podgorsak MB. Volumetric modulated arc therapy vs. IMRT for the treatment of distal esophageal cancer [J]. Med Dosim,2011,36(4) :404-409.
8Garow D. Metabolic syndrome is a risk factor for colorectal cancer in the United States[R]. American College of Gastroenterology 2008 Annual Scientific Meeting, October 6, 2008.
9Ahmed RL, Schmitz KH, Anderson KE, et al. The metabolic syndrome and risk of incident colorectal cancer[J]. Cancer, 2006, 107(1):28-36.
10American Society of Anesthesiologists. New classification of physical status[J]. Anesthesiology, 1963, 24:111.
